fucose has been researched along with Bowel Diseases, Inflammatory in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 4 (80.00) | 2.80 |
| Authors | Studies |
|---|---|
| Achasova, KM; Bets, VD; Borisova, MA; Kozhevnikova, EN; Litvinova, EA | 1 |
| Duan, C; Han, C; Hong, G; Hou, L; Hou, X; Qian, W; Tan, C; Wang, Z; Wu, J | 1 |
| Kononova, S; Pokrotnieks, J; Sitkin, S; Skalinskaya, M; Vakhitov, T | 1 |
| He, R; Hou, X; Ke, J | 1 |
| Hashii, N; Hee Ryu, S; Hoe Kim, J; Itoh, S; Kang, K; Kawasaki, N; Kim, JM; Kim, JY; Lee, SH; Park, SY | 1 |
5 other study(ies) available for fucose and Bowel Diseases, Inflammatory
| Article | Year |
|---|---|
Role of Mucin 2 Glycoprotein and L-Fucose in Interaction of Immunity and Microbiome within the Experimental Model of Inflammatory Bowel Disease.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Forkhead Transcription Factors; Fucose; Inflammatory Bowel Diseases; Intestinal Mucosa; Mice; Mice, Knockout; Microbiota; Models, Theoretical; Mucin-2 | 2022 |
Promoting Effect of L-Fucose on the Regeneration of Intestinal Stem Cells through AHR/IL-22 Pathway of Intestinal Lamina Propria Monocytes.
Topics: Animals; Fucose; Inflammatory Bowel Diseases; Interleukin-22; Intestinal Mucosa; Mice; Monocytes; Regeneration; Stem Cells | 2022 |
Gut Microbiota-Mediated Pleiotropic Effects of Fucose Can Improve Inflammatory Bowel Disease by Modulating Bile Acid Metabolism and Enhancing Propionate Production.
Topics: Bile Acids and Salts; Fucose; Gastrointestinal Microbiome; Humans; Inflammatory Bowel Diseases; Propionates | 2021 |
Reply to the Letter: Gut Microbiota-mediated Pleiotropic Effects of Fucose Can Improve Inflammatory Bowel Disease by Modulating Bile Acid Metabolism and Enhancing Propionate Production.
Topics: Bile Acids and Salts; Fucose; Gastrointestinal Microbiome; Humans; Inflammatory Bowel Diseases; Propionates | 2021 |
α1-3/4 fucosylation at Asn 241 of β-haptoglobin is a novel marker for colon cancer: a combinatorial approach for development of glycan biomarkers.
Topics: Aged; Asparagine; Biomarkers, Tumor; Colon; Colonic Neoplasms; Female; Fucose; Glycosylation; Haptoglobins; Humans; Inflammatory Bowel Diseases; Male; Polysaccharides | 2012 |